関連する実験動画
Updated: Sep 10, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.0K
トラウマにおけるトランキサム酸
Whitney J Barrett1, Kevin A Kaucher2, Ross E Orpet3
1Department of Emergency Medicine, University of New Mexico School of Medicine, Albuquerque, NM, National Association of EMS Physicians.
Annals of emergency medicine
|August 22, 2025
まとめ
トラウマケアにおけるトランキサム酸 (TXA) の使用は議論されている. 新しい証拠は,負傷した患者にTXAを静脈内投与する際の緊急医療サービス (EMS) の最新ガイドラインを裏付けています.
科学分野:
- 緊急 医療
- トラウマケア
- 薬理学について
背景:
- トラネキサム酸 (TXA) の病院前での使用は,過去10年間で著しく増加しました.
- トラウマ患者に対する広範囲のTXA投与の利点は矛盾する証拠がある.
- 負傷した患者に対する病院前TXAに関する以前のガイドラインは2016年に発行されました.
研究 の 目的:
- 負傷した患者に入院前でのTXAの使用について,最新の証拠に基づいた勧告を提供すること.
- 緊急医療サービス (EMS) に関するTXAに関する変化する研究状況に対処する.
主な方法:
- 最近の研究成果をまとめるために,構造化された文献レビューが行われました.
- 添付資料にまとめられた証拠に基づいて,勧告が策定された.
主要な成果:
- このレビューでは,病院前のTXA投与後の患者のアウトカムを調査する新しい研究が特定されました.
- この発見は,最新の臨床ガイドラインの作成を促した.
結論:
- EMS医師の全国協会,アメリカ 外科医会 トラウマ委員会,アメリカ 救急医師会が最新の勧告を提供している.
- これらの勧告は,負傷した患者に対する病院前でのTXAの適切な使用を指します.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Vascular Spasm
1.8K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K

